Ready to play
Ready to play
A comprehensive study found that the use of glucosamine supplements to treat joint pain is associated with a 25% increase in the likelihood of developing cognitive decline into dementia. It was also linked to higher mortality rates among dementia patients. Research shows that the effects of glucosamine are more pronounced in those already suffering from dementia, with possible explanations related to excessive glycosylation in the brain, which can impair neural functions. This raises questions about the impacts of this widely used supplement on mental health.
Notice: This Is an AI-Generated Summary
Comments (0)